0001237899-13-000043.txt : 20130612 0001237899-13-000043.hdr.sgml : 20130612 20130612091525 ACCESSION NUMBER: 0001237899-13-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130610 FILED AS OF DATE: 20130612 DATE AS OF CHANGE: 20130612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER CHARLES A CENTRAL INDEX KEY: 0001225470 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 13907981 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-06-10 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225470 BAKER CHARLES A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2013-06-10 4 M 0 15000.0 15.8 A 24000 D Common Stock 2013-06-10 4 S 0 4150.0 250.06 D 19850 D Common Stock 2013-06-10 4 S 0 3938.0 251.67 D 15912 D Common Stock 2013-06-10 4 S 0 4748.0 252.32 D 11164 D Common Stock 2013-06-10 4 S 0 908.0 253.5 D 10256 D Common Stock 2013-06-10 4 S 0 756.0 254.1 D 9500 D Common Stock 2013-06-10 4 S 0 200.0 255.16 D 9300 D Common Stock 2013-06-10 4 S 0 300.0 257.99 D 9000 D Common Stock 590 I by Partnership Non-Qualified Stock Option (right to buy) 15.8 2013-06-10 4 M 0 15000.0 D 2016-01-03 Common Stock 15000 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 4,150 shares of Company stock on June 10, 2013 at prices ranging from $250.00 to $250.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price. Represents volume-weighted average price of sales of 3,938 shares of Company stock on June 10, 2013 at prices ranging from $251.15 to $251.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price. Represents volume-weighted average price of sales of 4,748 shares of Company stock on June 10, 2013 at prices ranging from $252.00 to $252.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price. Represents volume-weighted average price of sales of 908 shares of Company stock on June 10, 2013 at prices ranging from $253.11 to $253.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price. Represents volume-weighted average price of sales of 756 shares of Company stock on June 10, 2013 at prices ranging from $254.04 to $254.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price. Represents volume-weighted average price of sales of 300 shares of Company stock on June 10, 2013 at prices ranging from $257.98 to $257.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2013 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Charles A. Baker 2013-06-11